◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

IOL Chemicals and Pharmaceuticals Limited (IOLCP) Financial History

Name: IOL Chemicals and Pharmaceuticals Limited (IOLCP) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-09-20

IOL Chemicals and Pharmaceuticals Limited (IOLCP) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Ludhiana, India with about 3,095 employees. Its market capitalization is roughly ₹60 billion. In the fiscal year ended 2026-03-31, IOLCP reported ₹23.1B in revenue and ₹1.4B in net income.

IOL Chemicals and Pharmaceuticals Limited manufactures and sells pharmaceutical and chemical products in India and internationally. It operates through two segments: Pharmaceuticals and Specialty Chemicals.

Interactive charts & full statements →

IOLCP Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Revenue	₹23.1B	₹20.7B	₹21.2B	₹22.0B
Gross Profit	₹7.9B	₹6.5B	₹7.0B	₹6.2B
Operating Income (EBIT)	₹1.9B	₹1.3B	₹1.7B	₹1.8B
Net Income	₹1.4B	₹1.0B	₹1.3B	₹1.4B

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

IOLCP Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Total Revenue	₹7.6B	₹6.2B	₹5.8B	₹5.7B	₹5.5B
Gross Profit	₹2.8B	₹2.5B	₹2.0B	₹2.0B	₹1.9B
Operating Income (EBIT)	₹822M	₹722M	₹371M	₹371M	₹424M
Net Income	₹644M	₹532M	₹206M	₹300M	₹339M

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

IOLCP Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(₹294M)	(₹235M)	(₹294M)	(₹235M)	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

IOLCP Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	₹25.9B	₹23.8B	₹22.4B	₹20.2B	—
Total Liabilities	₹7.9B	₹6.9B	₹6.3B	₹5.1B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive IOLCP viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

MOREPENLAB · Morepen Laboratories Limited — ₹66 billion
4569 · KYORIN Pharmaceutical Co., Ltd. — JPY 65 billion
SPARC · Sun Pharma Advanced Research Company Limited — ₹63 billion
4886 · ASKA Pharmaceutical Holdings Co.,Ltd. — JPY 62 billion
FDC · FDC Limited — ₹57 billion
GUJTHEM · Gujarat Themis Biosyn Limited — ₹56 billion
NOVARTIND · Novartis India Limited — ₹51 billion
ORCHPHARMA · Orchid Pharma Limited — ₹50 billion

← IOCT All “I” companies ION →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.